Man-12	
    			    			
                CMFTe002-A            
            
        General
Donor Information
General Donor Information | 
					|
| Sex | male | 
Phenotype and Disease related information (Donor) | 
					|
| Diseases | No disease was diagnosed.
																	 | 
					
| Is the medical history available upon request? | Yes | 
| Is clinical information available? | Yes | 
Karyotyping (Donor) | 
						|
| Has the donor karyotype been analysed? | 
								 Yes 								
																	
															 | 
						
Other Genotyping (Donor) | 
						|
| Is there genome-wide genotyping or functional data available? | 
								 Yes 								
																										
										Array CGH										
																				
																				
																			 
																								 | 
						
Donor Relations | 
							|
| All cell lines of this donor's relatives | 
																			 
												Has sister:
										 
																	 | 
							
External Databases (Donor) | 
						|
| BioSamples | SAMEA4760722 | 
Ethics
| Was the embryo established purely for research purposes? | No | 
| Have both parents consented to the use of the embryo for ESC derivation? | Yes | 
| Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes | 
| Was the consent voluntarily given? | Yes | 
| Alternatives to consent are available? | Yes | 
| Alternatives to consent | |
| Alternative consent approval number | |
| Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | pseudonymised | 
| Does consent explicitly allow the derivation of pluripotent stem cells? | Yes | 
| * Does consent expressly prevent the derivation of pluripotent stem cells? | No | 
| How may genetic information associated with the cell line be accessed? | |
| Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No | 
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes | 
| Name of accrediting authority involved? | HTA, HFEA and UK Stem Cell Bank | 
| Approval number | HTA Licence number: 22627 HFEA Licence number: R0171-3-A. UKSCB approval number: SCSC12-27 | 
hESC Derivation
| Date of derivation | 2011-08-27 | 
						
| Embryo stage | Blastula with ICM and Trophoblast | 
| Supernumerary embryos from IVF treatment? | 
								 Yes 
																											
											Separation of research and IVF treatment?
											 
																	
															Yes 										 | 
						
| PGD Embryo? | 
								 No 							 | 
						
| Expansion status | 
								1 
								 | 
						
| ICM morphology | 
								A 
								 | 
						
| Trophectoderm morphology | 
								a 
								 | 
						
| ZP removal technique | Chemical | 
| Cell isolation | Mechanical | 
| Cell seeding | Isolated ICM | 
| Derived under xeno-free conditions? | 
								 No 							 | 
						
| Derivation under GMP? | 
								 Yes 							 | 
						
| Available as clinical grade? | 
								 Yes 							 | 
						
Culture Conditions
| Surface coating | CELLstart | |||||||||
| Feeder cells | 
																								Human Dermal Fibroblast Cellfinder Ont Id: CELDA_000001419  | 
						|||||||||
| Passage method | Mechanically | |||||||||
| O2 Concentration | 20 % | |||||||||
| CO2 Concentration | 5 % | |||||||||
| Medium | 
								mTeSR™ 2		
				 Supplements 
				
  | 
						|||||||||
| Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | Unknown  | 
					|||||||||
| Has Rock inhibitor (Y27632) been used at cryo previously with this cell line? | Unknown  | 
					|||||||||
| Has Rock inhibitor (Y27632) been used at thaw previously with this cell line? | Unknown  | 
					
Characterisation
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles | 
| NANOG | 
											 Yes 						                 | 
																                
						                
						                	 | 
						                ||||
| SSEA-4 | 
											 Yes 						                 | 
																                
						                
						                	 | 
						                ||||
| TRA 1-60 | 
											 Yes 						                 | 
																                
						                
						                	 | 
						                ||||
| POU5F1 (OCT-4) | 
											 Yes 						                 | 
																                
						                
						                	 | 
						                ||||
| SOX2 | 
											 Yes 						                 | 
																                
						                
						                	 | 
						                ||||
| SSEA-1 | 
											 No 						                 | 
																                
						                
						                	 | 
						                
Differentiation Potency
In vitro spontaneous differentiation
					| Marker | Expressed | 
| GATA Binding Protein 6 | 
										 Yes 					                 | 
								
| FOXA2 | 
										 Yes 					                 | 
								
In vitro spontaneous differentiation
					| Marker | Expressed | 
| Actin, Alpha 2, Smooth Muscle, Aorta | 
										 Yes 					                 | 
								
| Vimentin | 
										 Yes 					                 | 
								
In vitro spontaneous differentiation
					| Marker | Expressed | 
| Tubulin Beta 3 Class III | 
										 Yes 					                 | 
								
| Neurofilament, light polypeptide | 
										 Yes 					                 | 
								
Microbiology / Virus Screening | 
						|
| HIV 1 | Negative | 
| HIV 2 | Negative | 
| Hepatitis B | Negative | 
| Hepatitis C | Negative | 
| Mycoplasma | Negative | 
Genotyping
Karyotyping (Cell Line) | 
					|
| Has the cell line karyotype been analysed? | 
								 Yes 								
																	
												Normal Male 46 XY
											 
																				
																					
																															
											Passage number: p14											 
																															
											Karyotyping method:
											G-Banding											
																						 
																			 | 
						
Other Genotyping (Cell Line) | 
					|
| Is there genome-wide genotyping or functional data available? | 
								 Yes 								
																											
											Array CGH											
																						
    																					
																					 
																								 | 
						

								
								
								
Login to share your feedback, experiences or results with the research community.